Small cylindrical glass bottle (b) stopped with a rubber stopper and sealed with a metal cap around vial neck and lipwith a plastic cap that is attached to the metal cap such that when the plastic cap is pulled off, the seal on the metal cap is broken; vial is in a cardboard box (a) with a paper le…
Small cylindrical glass bottle (b) stopped with a rubber stopper and sealed with a metal cap around vial neck and lipwith a plastic cap that is attached to the metal cap such that when the plastic cap is pulled off, the seal on the metal cap is broken; vial is in a cardboard box (a) with a paper leaflet (c)
Number Of Parts
3
Part Names
a - box - Size: Length 5.7 cm x Width 2.9 cm x Depth 2.9 cm
b - vial - Size: Length 4.4 cm x Diam. 2.2 cm
c - leaflet (unfolded) - Size: Length 17.6 cm x Width 10.1 cm
(a) Front: "DIN 248991 Stock 4-4079-63-70 // INFLUENZA VIRUS VACCINE, // TRIVALENT, TYPES A AND B // FLUOGEN® Subvirion Vaccine // Dose – Persons 27 years and older, a single injection of 0.5 ml; // persons 3 years through 26 years, 2 injections of 0.5 ml, 4 or // more weeks apart; persons 6 months through 35 months, 2 // injections of 0.25 ml, 4 or more weeks apart. Inject // intramuscularly. See package insert. // 5 ml PARKE-DAVIS"; bottom: "Standardized according to 1979-80 NACI and US PHS requirements. // Contains no less than 21 micrograms of HA antigen content per // 0.5 ml dose in the recommended ratio of 7µg of HA of the A // influenza virus component representative of A/Brazil/78 (H1N1), 7 // µg of HA of the A influenza virus component representative of // A/Texas/1/77 (H3N2), and 7µg of HA of the B influenza virus component representative of B/Hong Kong/5/72. The vaccine is of chick embryo origin. // Polysorbate 80, USP, added during manufacture. // Preservative: 0.01% thimer- // osal (mercury derivative). //Store at temperature between // 2° and 8° C (36° and 46° F). // Freezing destroys potency. // Exp date and lot [printed] // FEB. 5, 1981 // YH601 [stamped]"; back: front repeated in French; top: bottom repeated in French up to and including "Freezing destroys potency"] // Permis US n°1 Permis can. n°1 // Parke, Davis & Co/Detroit, Mi 48232 USA"; right side: "5 ml // FLUOGEN // U.S. Lic. No. 1 Can. Lic. No. 1 // PARKE-DAVIS"; left side: "5 ml // FLUOGEN // Stock 4-4079-63-70 // PARKE-DAVIS // Printed in USA // 120 // 457217"; (b) front: "DIN 248991 C // INFLUENZA VIRUS VACCINE, TRIVALENT // TYPES A AND B FLUOGEN® Subvirion // Vaccine // [contents as listed on box front] // The vaccine is of chick embryo origin. // 5 ml PARKE-DAVIS"; back: "LOT YH607 [stamped] // Dose – See package insert. // Standardized according to // the NACI and the US PHS // requirements for the // 1979-80 season. // Stock 4-4079-63-70 // U.S. Lic. No. 1 Can Lic. No. 1 [printed] // EXP FEB. 5, 1981 [stamped] // Parke, Davis & Co // Detroit, Mi 48232 USA // 02 4079 70 1 [printed]"; bottom: "W // 79 [embossed]"; top: "FLIP // OFF [embossed]"; (c) "FLUOGEN® // (INFLUENZA VIRUS VACCINE, TRIVALENT, TYPES A AND B) // Subvirion Vaccine/Immunizing Antigen, Ether Extracted // DESCRIPTION // [text follows] // ACTION // [text follows] // PARKE-DAVIS // 121 887150/C-KF // FLUOGEN // (INFLUENZA VIRUS VACCINE, TRIVALENT, TYPES A AND B) // [text continues from Action] // INDICATIONS // 2 121 887150/C-KF // FLUOGEN // (INFLUENZA VIRUS VACCINE, TRIVALENT, TYPES A AND B) // [text continues from Indications] // CONTRAINDICATIONS // [text follows] // WARNING // [text follows] // PRECAUTIONS // [text follows] // USAGE IN PREGNANCY // [text follows] // ADVERSE REACTIONS // 3 121 887150/C-KF // FLUOGEN // (INFLUENZA VIRUS VACCINE, TRIVALENT, TYPES A AND B) // [text continues from Adverse Reactions] // DOSAGE AND ADMINISTRATION // [text follows] // STORAGE // [text follows] // PACKAGE INFORMATION // [text follows] // Unpublished data available upon request. // Issued June 1979 // Parke, Davis & Co., Detroit, Mi 48232 USA 121 887150/C-KF // [French translation accompanies English text throughout]"
Permanent Location
Storage Room 0010
0010-A3-5 Row G
Condition Remarks
Box somewhat yellowed, dented; no apparent problems with vial or leaflet
Copy Type
Original
Research Facts
This is a vaccine against the influenza virus and is administered intramuscular with a hypodermic syringe.